Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder

JB Kopp - Current opinion in nephrology and hypertension, 2013 - journals.lww.com
Current opinion in nephrology and hypertension, 2013journals.lww.com
APOL1 nephropathy comprises a disease spectrum (perhaps with distinct endophenotypes),
including focal segmental glomerulosclerosis, collapsing glomerulopathy, and
arterionephrosclerosis. The terms hypertensive kidney disease and hypertensive
nephrosclerosis have outlived their usefulness. It may be time to use the established,
etiologically neutral term, arterionephrosclerosis, to consider whether this is a disease rather
than a pathologic description, and to determine the causal role of various clinical correlates …
Summary
APOL1 nephropathy comprises a disease spectrum (perhaps with distinct endophenotypes), including focal segmental glomerulosclerosis, collapsing glomerulopathy, and arterionephrosclerosis. The terms hypertensive kidney disease and hypertensive nephrosclerosis have outlived their usefulness. It may be time to use the established, etiologically neutral term, arterionephrosclerosis, to consider whether this is a disease rather than a pathologic description, and to determine the causal role of various clinical correlates including aging, obesity, hyperlipidemia, smoking, chronic inflammation, and oxidative stress.
Lippincott Williams & Wilkins